Background/Aims: LukS-PV is a component of Panton-Valentine leukocidin (PVL). We have previously demonstrated that LukS-PV potently promoted differentiation and induced apoptosis in THP-1 cells. However, the precise mechanisms of these actions remain unknown. MicroRNAs (miRs) play important roles in cellular differentiation and apoptosis. This study aimed to investigate the role of miR-125a-3p in LukS-PV-regulated differentiation and apoptosis and its underlying mechanism in THP-1 cells. Methods: MicroRNA profiling analyses were conducted to determine differential miRNA expression levels in THP-1 cells treated with LukS-PV. Cell differentiation and apoptosis were measured in THP-1 cells by gainof-function and loss-of-function experiments. Bioinformatics analysis and luciferase reporter assays were used to confirm the targets of miR-125a-3p. The effects of the miR-125a-3p targets on cellular differentiation were determined by knocking them down. Results: MiR125a-3p was up-regulated after treating the human monocytic leukaemia cell line THP-1 with LukS-PV. In addition, miR-125a-3p positively regulated apoptosis and differentiation in THP-1 cells treated with LukS-PV. Concordantly, luciferase reporter assays confirmed that neurofibromatosis type 1 (NF1) and B-cell lymphoma 2 (Bcl-2) were direct target genes of miR-125a-3p. Moreover, NF1 knockdown in THP-1 cells significantly promoted differentiation in vitro. Finally, the extracellular signal-regulated kinase (ERK) pathway, a downstream target of NF1, was activated after NF1 knockdown. Conclusions: These findings confirm that miR125a-3p is involved in LukS-PV-mediated cell differentiation and apoptosis in THP-1 cells.
LukS-PV-Regulated

Introduction
LukS-PV is a component of Panton-Valentine leukocidin (PVL), which is secreted by Staphylococcus aureus and targets human polymorph nuclear neutrophils (PMNs) [1] . Our previous studies have demonstrated that a long exposure (48 h) to LukS-PV resulted in THP-1 monocyte differentiation, and a short exposure (24 h ) to LukS-PV led to THP-1 cell apoptosis [2, 3] . These results identified that LukS-PV plays a crucial role in THP-1 cell differentiation and apoptosis. However, its precise molecular mechanism has not been determined.
MicroRNAs (miRs) are 19-25 nucleotide, double-stranded non-coding RNAs that regulate gene products at the post-transcriptional level [4] . Variant miR expression is frequently observed in many types of cells and plays an important role in cellular differentiation and apoptosis [5, 6] . The biological function of miRs in THP-1 biological development involves the regulation of differentiation and apoptosis; for example, miR-149-5p inhibition induces apoptosis in THP-1 cells by targeting FASLG [7] , and miR-199a-5p inhibition significantly promoted THP-1 monocyte differentiation into macrophages by targeting the activin A type 1B receptor gene [8] . In our study, we examined the differential expression of miRs using a miRNA expression profile analysis of THP-1 cells stimulated with LukS-PV. We found that microRNA-125a-3p (miR-125a-3p) expression was significantly increased more than that of any other miR. MiR-125a-3p, an isoform derived from the 3´-arm of pre-miR-125a, has been reported to be involved in apoptosis in various cells, such as the lung cancer cell line H1299, the glioma cell line U251, and the acute myeloid leukaemia cell lines HL-60 and NB4 [9] [10] [11] . Moreover, miR-125a-3p also regulates cell differentiation [12] . However, the role of miR-125a-3p in THP-1 cells treated with LukS-PV remains unknown.
THP-1, a human monocytic leukaemia cell line, best resembles primary monocytes. In addition, THP-1 cells are the most commonly utilized cell line to study monocyte/macrophage differentiation and function [13] . THP-1 cells have some major advantages over primary monocytes in experiments; these advantages include a homogenous genetic background that prevents donor variability and ensures reproducibility [14] . Monocytes and monocytederived macrophages play an essential role during infection, and their functions seem to be key factors in many immune disorders. Until now, the data on monocyte/macrophage dysfunction have been limited to a few reports, and the exact mechanism underlying these processes has not been proposed. However, recent studies have shown that miRs may be involved in the regulation of macrophage function. For example, the early secreted antigenic target 6-kDa protein (ESAT-6) promotes apoptosis in macrophages via targeting the miRNA155-SOCS1 interaction [15] , microRNA-155 enhances the atherosclerosis inflammatory response in macrophages by targeting SOCS1 [16] , and miR-146a regulates inflammation in macrophages by targeting TRAF6 [17] . In this study, we used THP-1 cells to investigate the role of miR-125a-3p in monocyte function after exposure to LukS-PV. Specifically, we focused on the effects of miR-125a-3p on apoptosis and differentiation. We also examined how LukS-PV regulates THP-1 cell differentiation and apoptosis through miR125a-3p.
Materials and Methods
Cell culture
The human monocytic leukaemia cell line THP-1 was obtained from the Shanghai Institute for Biological Sciences (Shanghai, PR China). Cells were cultured in RPMI-1640 (Gibco, Grand Island, NY, USA) supplemented with 10% foetal bovine serum (FBS, HyClone, Logan, UT) and 1% penicillin/streptomycin in a humidified 5% CO 2 incubator at 37°C. Cells were passaged two to three times per week to maintain logarithmic phase growth.
Recombinant LukS-PV production and purification pET28a (Roche Diagnostics Corp, Basel, Switzerland) was used to produce recombinant hexa-Histagged LukS-PV. The sequence was amplified from PVL-positive S. aureus isolates. PCR products were [18] ..
MicroRNA profiling analysis
THP-1 cells treated with 1.0 μM LukS-PV for 48 h and control cells were collected for microRNA profiling analysis. Total RNA extracted from THP-1 cells was reverse transcribed using the miRCURY Locked Nucleic Acid (LNA™) Universal Reverse Transcription microRNA PCR, Polyadenylation and cDNA synthesis kit (Exiqon). Then, to identify differentially expressed miRNAs, the samples were subjected to the Exiqon miRCURY Ready-to-Use PCR Human Panel I+II (Exiqon miRNA qPCR panel, Vedbaek, Denmark), which could detect 772 miRNAs in cells, and run on a 7900HT real-time PCR system (Applied Biosystems, Foster City, CA, USA). The method used 384-well PCR plates, and pre-aliquoted LNA™ PCR primers were added to each well. cDNA was pre-amplified by SP6 primers. After identifying Ct reunification values, follow-up experiments were performed. The fold-change in the expression of each miRNA was calculated by using the 2 −ΔΔCt method. MiRs were considered to be up-regulated or down-regulated if the changes in expression were ≥ 2.0-fold or ≤ 2.0-fold, respectively.
RNA isolation and real-time RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) according to the manufacturer's instructions. Reverse transcription for gene expression or miR expression was performed using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, Vilnius, Lithuania). All RT-PCR reactions were carried out using a StepOnePlus RT-PCR system (Applied Biosystems, Carlsbad, CA, USA). To measure gene expression, quantitative realtime PCR (RT-qPCR) was conducted using the SYBR Green PCR Kit (QIAGEN, Hilden, Germany) according to the manufacturer's protocol. The data were processed by the comparative cycle threshold method and are expressed as fold increases relative to the basal transcription level. The amount of target mRNA was normalized to GAPDH. For quantitative RT-PCR of miRs, the cDNA products used for PCR were generated as described before. miR expression was measured using the TaqMan miRNA Kit (GenePharma, Shanghai, PR China) according to the manufacturer's instructions. Mature miRs were normalized to U6-snRNA. Relative expression was calculated using the comparative Ct method. All the primer sequences used in this study are listed in Table 1 .
Lentiviral transduction
THP-1 cells were transduced with lentiviral vectors expressing has-miR-125a-3p, an inhibitor of hasmiR-125a-3p expression or an neurofibromatosis type 1 (NF1)-targeting shRNA (Genechem, Shanghai, PR China). Lentiviruses at a multiplicity of infection (MOI) between 50 and 70 were added to THP-1 cells at 37°C. For controls, lentiviral vectors containing short hairpin sequences targeting a non-mammalian gene were used at similar MOIs. Cells were infected for 24 h and then maintained in culture medium.
Morphology assay
Cells were cultured at a density of 1 × 10 6 cells per well in six-well plates. Cell morphology was examined by staining with a modified Wright-Giemsa solution and using an optical microscope (Nikon, Tokyo, Japan).
Flow cytometry
For immunophenotyping, cells were harvested by centrifugation at 1000 × g for 5 min, washed twice in cold PBS, 
Has-miR-125a-3p-F ATCTGACACAGGTGAGGTTCTTG
Has-miR-125a-3p-R TATGGTTTTGACGACTGTGTGAT
Has-miR-181a-3p-F AGAATTACACCATCGACCGTTG
Has-miR-181a-3p-R TATGCTTGTTCTCGTCTCTGGTC
Has-miR-761-F ATTACTTGCAGCAGGGTGAAAC
Has-miR-761-R
TATGCTTGTTCTCGTCTCTGTGTC U6-F ATTGGAACGATACAGAGAAGATT U6-R GGAACGCTTCACGAATTTG GAPDH-F GGAGCGAGATCCCTCCAAAAT GAPDH-R GGCTGTTGTCATACTTCTCATGG NF1-F CACTGGTCCAGCCTTAACCT NF1-R TAGGATTCCCAGCTTTGGAG Bcl-2-F GAAGCACAGATGGTTGATGC Bcl-2-R CAGCCTCACAAGGTTCCAAT
Western blotting
After the various treatments, cells were lysed in lysis buffer with protease inhibitor cocktail, 1 mmol/L sodium fluoride and 1 mmol/L sodium orthovanadate. Proteins (40 μg) were separated on 12% SDS-polyacrylamide gels and electrophoretically transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA, USA). The membranes were blocked with 10% milk in Tris-buffered saline/0.1% Tween-20 for 2 h and subsequently probed with primary antibodies. Then, the membranes were incubated with a horseradish peroxidase-conjugated secondary antibody for 1 h. Immunoreactive bands were visualized with an enhanced chemiluminescence detection system. All of the rabbit anti-human primary antibodies were purchased from Cell Signaling Technology.
Cell cycle analysis
The cells were harvested by centrifugation at 2000 rpm for 10 min, washed twice with cold PBS, and resuspended in cold 75% ethanol. Cell cycle analyses were performed using the BD Pharmingen TM PI/RNase staining buffer and flow cytometry according to the manufacturer's instructions.
Caspase-3 activity assay
Caspase-3 activity was measured by fluorometric assay (Beyotime Biotechnology, Shanghai, PR China) according to the manufacturer's instructions. Briefly, cells were homogenized with lysis buffer, and lysates were centrifuged at 20000 × g for 15 min at 4°C. Subsequently, the supernatants were treated with Ac-DEVD-pNA at 37°C for 6-8 h. Samples were read at 405 nm (ELX808U, Bio-Tek, USA). Caspase activation is expressed as the relative increase compared with the controls.
MiR-125a-3p target prediction and luciferase reporter assays
Three bioinformatics databases were used for the in silico prediction of miR-125a-3p targets: miRBase, miRanda and TargetScan. Predicted target genes that were common in at least 2 of the 3 databases were chosen for luciferase assays. For the luciferase assays, HEK 293T cells were transfected with miR-125a-3p mimics or with the empty miR non-specific control (NC) (GenePharma) and wild-type, mutated NF1 or B-cell lymphoma 2 (Bcl-2) 3´-UTR plasmids (constructed by GenePharma) using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA). Luciferase activities were measured at 24 h post-transfection using the dual-luciferase assay system (Promega, Madison, WI, USA). Luminescence readings were acquired using a Flexstation 3 Multiscan Spectrum (Molecular Devices, Sunnyvale, CA, USA).
Statistical analysis
All data are expressed as the mean ± standard deviation (SD), and all experiments were performed in triplicate. Statistical analyses shown in the figures were performed using t-tests or one-way ANOVA. All statistical analyses were conducted using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). A value of p < 0.05 was considered statistically significant.
Results
Identification of differential miR-125a-3p expression in LukS-PV-treated THP-1 cells
We examined the expression levels of 772 miRs in LukS-PV-treated THP-1 cells in vitro through miRNA expression profile analysis. We found that 161 miRs were up-regulated, whereas 35 miRs were down-regulated. The scatterplot and cluster graph of the profile results are shown in Fig. 1A and 1B. The data showed that the miR with the highest-fold increase was miR-125a-3p (102.5-fold), followed by miR-181a-3p (58.79-fold); miR-761 showed the highest-fold decrease (18.82-fold). These findings indicated that these Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry differentially expressed miRs might be associated with THP-1 cell differentiation and apoptosis induced by LukS-PV. To validate the results of the miRNA expression profile, we measured the expression levels of miR-125a-3p, miR-181a-3p and miR-761 in THP-1 cells treated with 1.0 μM LukS-PV for 48 h by real-time RT-PCR. These results were inconsistent with the profile analysis regarding the specific fold changes because of the different methods and test frequency. However, as shown in Fig. 1C , the tendency of the miRs to increase or decrease was consistent with the profile analysis. For this study, we selected miR-125a-3p and investigated its role in the effects of LukS-PV on THP-1 cells.
MiR-125a-3p is involved in the differentiation of LukS-PV-treated THP-1 cells
To investigate whether miR-125a-3p expression is correlated with THP-1 cell differentiation, THP-1 cells were transfected with miR-125a-3p over-expression or miR-125a-3p NC lentiviral vectors. Wright-Giemsa staining was first used to evaluate the differentiation potential of the two cell populations. As shown in Fig. 2A , cells in the miR-125a-3p-overexpressing group exhibited greater cytoplasmic-to-nuclear ratios and larger sizes than cells in the miR-NC group, which appeared to be predominantly myelocytes with round, regular cell margins and large nuclei. Then, we calculated the percentages of differentiated cells 
in each group. The percentage of differentiated cells was increased to 8.36% in the miR125a-3p-over-expressing group but to only 1.78% in the miR-NC group (Fig. 2B) . Next, flow cytometry and western blotting assays were used to further investigate the differentiation potential of the two cell populations. As shown in Fig. 3A and 3C, miR-125a-3p overexpression clearly increased the expression levels of the cell surface differentiation antigens CD11b and CD14 and up-regulated the phosphorylation levels of the differentiation-related proteins extracellular signal-regulated kinase (ERK), c-JUN and c-FOS. To validate whether the LukS-PV-mediated induction of THP-1 cell differentiation required miR-125a-3p activity, miR-125a-3p was silenced by transfecting an inhibitory miR125a-3p construct. Then, the effects of LukS-PV on differentiation marker expression levels were determined as before. First, we carried out a morphology analysis. As shown in Fig. 2C , obvious differentiation was observed in the cells treated with 1.0 μM LukS-PV for 48 h. These cells had an increased cytoplasmic/nuclear ratio and chromatin condensation. Differentiation was significantly decreased in the cells expressing the miR-125a-3p-inhibiting construct and incubated with LukS-PV. Next, we calculated the percentages of differentiated cells in each group. The percentage of differentiated cells was increased from 2.38% to 21.38% after LukS-PV treatment but was then decreased to 8.78% when the miR-125a-3p-inhibiting construct was added (Fig. 2D) . Additionally, in THP-1 cells treated with LukS-PV, silencing miR-125a-3p considerably suppressed CD11b and CD14 expression (Fig. 3D) . Moreover, the levels of phosphorylated ERK, c-JUN and c-FOS (Fig. 3F) were also reduced. These results demonstrate that the up-regulation of miR-125a-3p may be responsible for the effects of LukS-PV on differentiation in THP-1 cells.
MiR-125a-3p is involved in cell cycle and apoptosis regulation in LukS-PV-treated THP-1 cells
Our previous study confirmed that LukS-PV could induce cell cycle arrest and apoptosis in THP-1 cells. To investigate whether miR-125a-3p is involved in these processes, we examined the cell cycle phase distribution of treated cells by flow cytometry. Caspase-3 activity and western blotting assays were used to measure the expression levels of apoptotic markers. The results showed that miR-125a-3p over-expression significantly induced G0/G1 phase arrest and decreased the percentage of cells in the S phase ( Fig. 4A and 4B) . Moreover, as shown in Fig. 5A and 5B, miR-125a-3p over-expression also significantly increased caspase-3 activity and expression levels of the pro-apoptotic proteins caspase-3, caspase-8, caspase-9 and Bax; miR-125a-3p over-expression decreased the expression levels of the anti-apoptotic protein Bcl-2 in THP-1 cells. When blocking the function of miR-125a-3p by transfecting the targeted miR sponge into THP-1 cells, the effects of LukS-PV on cell cycle and apoptosis were remarkably reduced. As shown in Fig. 4C and 4D , after the miR-125a-3p-inhibited group was treated with LukS-PV for 24 h, the percentage of cells in the G0/G1 phase decreased but increased in the S phase. In addition, the caspase-3 activity and pro-apoptotic protein levels decreased, whereas the expression of anti-apoptotic proteins increased in the miR-125a-3p-inhibited group after LukS-PV treatment for 24 h (Fig. 5C and 5D ). These findings strongly suggest that miR125a-3p up-regulation may be involved in the LukS-PV-mediated cell cycle and apoptosis regulation in THP-1 cells.
MiR-125a-3p directly targets NF1 and Bcl-2
MiRs generally exert their function by blocking the expression of their target genes. To investigate the targets of miR-125a-3p in THP-1 cells, a bioinformatics prediction was used to analyse and identify potential target genes. From these results, we found that the NF1 
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and Bcl-2 3´-untranslated regions (3´-UTRs) contained sites complementary to miR-125a-3p ( Fig. 6A and 6B ).
To validate whether NF1 and Bcl-2 are targets of miR-125a-3p, we separately cloned fragments of the NF1 and Bcl-2 3´-UTRs that contained wild-type or mutated miR-125a-3p-binding sequences into the psi-CHECK2 luciferase reporter plasmid. When the miR-125a-3p mimics were co-transfected with the reporter plasmid into HEK 293T cells, the relative luciferase activities of the reporter containing the wild-type NF1 or Bcl-2 3´-UTRs were significantly suppressed; however, the luciferase activities of the reporter containing the mutated NF1 or Bcl-2 3´-UTRs were unaltered ( Fig. 6C and 6D ). These findings indicate that miR-125a-3p directly targets the 3´-UTRs of NF1 and Bcl-2.
To further verify the relationship between miR-125a-3p and NF1 and Bcl-2, qRT-PCR was performed to examine the effects of miR-125a-3p over-expression on NF1 and Bcl-2 expression levels in THP-1 cells. The data showed a significant inverse correlation between miR-125a-3p expression and NF1 and Bcl-2 mRNA levels ( Fig. 6E and 6F ). These results demonstrate that miR-125a-3p can directly down-regulate NF1 and Bcl-2 expression in THP-1 cells.
NF1 loss promotes differentiation by activating the ERK pathway in THP-1 cells
NF1 is a GTPase activating protein that terminates Ras signalling. Few studies have investigated the role of NF1 in acute myelogenous leukaemia (AML) cell differentiation. To investigate the relationship between NF1 and THP-1 cell differentiation, we knocked down NF1 in THP-1 cells and conducted functional experiments. NF1 expression was decreased by 50% in THP-1 cells transfected with NF1 knockdown (KD) lentiviral vectors compared with that in cells transfected with the NC vectors (Fig. 7A) . As shown in Fig. 7B and 7C, NF1 knockdown increased CD11b and CD14 expression levels and up-regulated the phosphorylation of the differentiation-related proteins ERK, c-JUN and c-FOS. These results suggested that down-regulating NF1 promoted THP-1 cell differentiation by activating the ERK pathway. 
Discussion
PVL consists of two components, LukS-PV and LukF-PV. During infection, LukS-PV specifically binds to receptors on the plasma membrane of PMNs and then combines with LukF-PV to form an octamer that plays a key role in membrane perforation [19] . Recent studies have demonstrated that sublytic amounts of PVL can activate protective host immunity and enhance PMN phagocytosis [20, 21] . LukS-PV is not cytotoxic when used alone [1, 19, 22] . Our earlier work on LukS-PV was the first report to demonstrate that it promotes differentiation and apoptosis in THP-1 cells in vitro [2, 3] . However, the precise mechanisms through which LukS-PV exerts these functions in THP-1 cells are poorly understood.
Recent evidence has shown that differential miR expression levels are correlated with cellular responses to agents. MicroRNAs usually bind to the 3´-UTRs of target mRNAs; this binding results in translational suppression or mRNA degradation of numerous target genes [4] . According to many studies, chemicals can induce various effects in various cell types and regulate the expression of miRs. For instance, metformin can reduce miR-222 expression in the human lung cancer cell line A549 to inhibit cancer cell growth and cell cycle progression [23] . Additionally, Liu et al. reported that miR-143 expression was downregulated in shikonin-treated glioblastoma stem cells (GSCs) and that miR-143 targets BAG3 to promote GSC apoptosis [24] . In our analysis, we found that miR-125a-3p expression was induced following LukS-PV treatment in THP-1 cells. Moreover, the results obtained from gain-of-function and loss-of-function approaches indicated that miR-125a-3p is involved in regulating differentiation and apoptosis in THP-1 cells in vitro. Lentiviral-mediated miR125a-3p over-expression increased the expression levels of standard differentiation and apoptosis markers in THP-1 cells. These results confirm that miR-125a-3p acts as a cellular biological function regulator in THP-1 cells. MiR-125a-3p expression was down-regulated by the miR-silencing construct. This effect decreased the ability of LukS-PV to induce differentiation and apoptosis in THP-1 cells. These data confirm that miR-125a-3p plays a key role in the effects of LukS-PV on THP-1 cells.
To gain insight into the underlying molecular mechanisms through which miR-125a-3p influences differentiation and apoptosis in THP-1 cells, we used bioinformatics to predict its possible target genes. As shown in the database, NF1 and Bcl-2 were found to be targets of miR-125a-3p. Luciferase activity assays further confirmed that miR-125a-3p could directly target NF1 and Bcl-2. NF1 encodes a GAP that terminates Ras/mitogen-activated protein [25] [26] [27] . Functional studies have indicated that NF1 participates in signalling pathways that are responsible for a variety of cellular processes. Nevertheless, the link between NF1 and differentiation in THP-1 cells has not been reported. Our results also indicated that LukS-PV can activate the ERK pathway to promote THP-1 cell differentiation [2] . For these reasons, we speculated that LukS-PV-regulated miR125a-3p expression targets NF1 to promote THP-1 cell differentiation by activating the ERK pathway. In support of this hypothesis, we knocked down NF1 and found that ERK signalling and differentiation marker expression were promoted in THP-1 cells. However, many studies have shown that NF1 acts as a differentiation promoter to regulate leukaemia cells [28, 29] , and these results are not consistent with ours. This discrepancy suggests that NF1 has various regulatory effects in different cellular contexts. Bcl-2 is a key negative regulator of apoptosis that controls intracellular Ca 2+ release, oxygen free radical metabolism, and signal transduction pathways [30, 31] . Previous studies have reported that Bcl-2 regulates apoptosis by forming homodimers with Bax to prevent its release; thus, there is a relationship between Bcl-2 deficiency and increased Bax signalling [32] . In addition, Bcl-2 can inhibit cytochrome C release into the cytosol; this action activates caspase-3, caspase-8 and caspase-9 and leads to apoptosis [33] . Together, our results indicate that miR-125a-3p suppresses Bcl-2 expression to allow downstream caspase signalling activation to promote apoptosis in THP-1 cells.
The cellular response to any agent undoubtedly differs by cell type and treatment duration, and one agent may induce various effects by activating different regulatory mechanisms. In our study, we found that LukS-PV-regulated miR-125a-3p promotes THP-1 cell differentiation by targeting the NF1/ERK pathway while also promoting apoptosis by targeting the Bcl-2/caspase pathway (Fig. 8) . Taken together, our results suggest that LukS-PV stimulates miR-125a-3p expression, which plays a critical role in THP-1 monocytes.
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